Telaprevir-Based Triple Therapy for Re-Treatment Chronic HCV Patients With Genotype 1, Including the Null-Response: A Single Center Experience From Turkey

Virology: Research and Reviews
doi 10.15761/vrr.1000109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Access Text Pvt, Ltd.


Related search